Trending News
News
News
Dynavax Initiates Proof of Mechanism Trial in Lupus Patients
Milestone payment from GlaxoSmithKline earned.
News
MorphoSys Initiates Phase 1b Clinical Trial with MOR103 in Patients with MS
Data for the trial is expected to be available in 2013.
News
Fluxion Biosciences to Distribute Millipore PrecisION® Ion Channel Cell Lines
Combination with IonFlux™ automated patch clamp system creates a validated, affordable solution for ion channel profiling and screening.
News
Chikungunya Vaccine Trial Begins to Enroll Participants
NIH scientists developed experimental vaccine.
News
Hua Gong Named Executive Director of Medical Diagnostics at Premier Research
Dr. Gong to oversee the In Vitro Diagnostics business within the company.
News
Warnex to Sell its Analytical Services Division
Closing of the transaction is expected to occur on or about January 15, 2012.
News
Christopher C. Peters Joins Cornerstone Environmental Group
New client manager to focus on client relations and business development.
News
SGS Acquires MSM, MRL, Özel Hatay and Sanilab in Turkey
Founded between 2006 and 2009, MSM, MRL, Özel Hatay and Sanilab are privately owned laboratories in the growing Turkish food market.
News
Pacira Pharmaceuticals, Inc. Announces Results from EXPAREL™ Pivotal Trial
Data demonstrate significant reduction in cumulative pain scores and opioid use with EXPAREL in soft tissue surgical model.
News
Oxygen Biotherapeutics Names Two New Board Members with Pharmaceutical Industry, Product and Business Development Emphasis
The company has named Chris A. Rallis, Executive-in-Residence at Pappas Ventures, and Anthony A. DiTonno, President and Chief Executive Officer of Neurogesx Inc., to serve as members of the company's Board of Directors. The addition of these two directors increases the Board to five members.
Advertisement